glp-1 medication semaglutide vs. Other Receptor Agonists Understanding semaglutide (GLP-1 RA): Are

The label notes, In Zepbound clinical trials, hair loss was reported more frequently in female than male patients in the Zepbound (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups. Treatments for hair loss Experts say telogen effluvium with GLP-1 use is typically temporary, but people who develop hair loss should seek medical evaluation

Currently, Wegovy and Zepbound are the only GLP-1 receptor agonists FDA-approved for treating obesity

People with serious gastrointestinal conditions, like gastroparesis or uncontrolled inflammatory bowel disease, should not take GLP-1 medications

Results Activating GLP-1R with liraglutide attenuated pulmonary inflammation and fibrosis in mice exposed to silica